Lastest Insider Transactions Of Revance Therapeutics, Inc. ( RVNC ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | 2024-03-15 | Sell | 9,211 | 5.04 | 46,446 | 2024-03-19 18:45:36 |
RVNC | Revance Therapeutics, Inc. | Moxie Dwight | CLO & GC | 2024-03-15 | Sell | 8,125 | 5.04 | 40,971 | 2024-03-19 18:44:55 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2024-03-15 | Sell | 9,361 | 5.04 | 47,204 | 2024-03-19 18:44:03 |
RVNC | Revance Therapeutics, Inc. | Foley Mark J | CEO | 2024-03-06 | Buy | 30,000 | 6.98 | 209,400 | 2024-03-08 16:33:10 |
RVNC | Revance Therapeutics, Inc. | Moxie Dwight | SVP, GC & Secretary | 2023-09-05 | Sell | 34,853 | 17.58 | 612,624 | 2023-09-07 17:37:42 |
RVNC | Revance Therapeutics, Inc. | Foley Mark J | CEO | 2023-08-03 | Sell | 26,279 | 22.57 | 593,151 | 2023-08-04 17:07:53 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2023-06-30 | Sell | 1,701 | 25.04 | 42,593 | 2023-07-05 21:11:46 |
RVNC | Revance Therapeutics, Inc. | Foley Mark J | CEO | 2023-06-30 | Sell | 26,279 | 24.94 | 655,333 | 2023-07-05 21:11:06 |
RVNC | Revance Therapeutics, Inc. | Kolaja Carey OConnor | Directior | 2023-06-15 | Sell | 2,500 | 28.24 | 70,600 | 2023-06-20 16:25:04 |
RVNC | Revance Therapeutics, Inc. | Kolaja Carey OConnor | Directior | 2023-06-15 | Option Exercise | 2,500 | 18.12 | 45,300 | 2023-06-20 16:25:04 |
RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | 2023-06-09 | Sell | 5,000 | 30.82 | 154,096 | 2023-06-13 20:09:49 |
RVNC | Revance Therapeutics, Inc. | Foley Mark J | CEO | 2023-06-09 | Sell | 31,279 | 30.72 | 960,928 | 2023-06-13 20:09:32 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2023-06-01 | Sell | 3,201 | 30.64 | 98,070 | 2023-06-05 18:06:03 |
RVNC | Revance Therapeutics, Inc. | Moxie Dwight | SVP, GC & Secretary | 2022-02-02 | Sell | 21,401 | 34.55 | 739,338 | 2023-05-16 20:29:46 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2022-02-02 | Sell | 21,401 | 34.55 | 739,338 | 2023-05-16 20:29:33 |
RVNC | Revance Therapeutics, Inc. | Foley Mark J | CEO | 2022-02-02 | Sell | 70,447 | 34.55 | 2,433,726 | 2023-05-16 20:29:16 |
RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | 2022-02-02 | Sell | 21,015 | 34.55 | 726,003 | 2023-05-16 20:29:01 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2023-05-01 | Sell | 3,201 | 31.70 | 101,472 | 2023-05-02 16:01:32 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2023-04-03 | Sell | 3,201 | 32.15 | 102,912 | 2023-04-04 16:24:26 |
RVNC | Revance Therapeutics, Inc. | Moxie Dwight | SVP, GC & Secretary | 2022-09-22 | Sell | 18,496 | 31.59 | 584,220 | 2023-03-09 21:46:22 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2022-09-22 | Sell | 18,517 | 31.59 | 584,884 | 2023-03-09 21:46:08 |
RVNC | Revance Therapeutics, Inc. | Sjuts Dustin S | President | 2022-09-22 | Sell | 21,508 | 31.59 | 679,358 | 2023-03-09 21:45:52 |
RVNC | Revance Therapeutics, Inc. | Foley Mark J | CEO | 2022-09-22 | Sell | 70,390 | 31.59 | 2,223,360 | 2023-03-09 21:45:39 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2023-03-01 | Sell | 3,201 | 33.50 | 107,234 | 2023-03-02 21:25:57 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2023-01-31 | Sell | 3,201 | 34.60 | 110,755 | 2023-02-02 21:38:15 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2023-01-20 | Sell | 1,000 | 31.00 | 31,000 | 2023-01-23 17:35:36 |
RVNC | Revance Therapeutics, Inc. | Schilke Tobin | CFO | 2023-01-09 | Sell | 3,701 | 27.16 | 100,525 | 2023-01-10 20:06:54 |